Mettler-Toledo International, Inc. $MTD Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC decreased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 2.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,904 shares of the medical instruments supplier’s stock after selling 63 shares during the period. Yousif Capital Management LLC’s holdings in Mettler-Toledo International were worth $3,411,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also modified their holdings of the company. Greenleaf Trust raised its holdings in shares of Mettler-Toledo International by 1.2% in the first quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock valued at $1,030,000 after buying an additional 10 shares during the last quarter. Brooklyn Investment Group raised its holdings in shares of Mettler-Toledo International by 12.8% in the first quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 10 shares during the last quarter. Sax Wealth Advisors LLC raised its holdings in shares of Mettler-Toledo International by 2.8% in the second quarter. Sax Wealth Advisors LLC now owns 372 shares of the medical instruments supplier’s stock valued at $437,000 after buying an additional 10 shares during the last quarter. Sequoia Financial Advisors LLC increased its stake in shares of Mettler-Toledo International by 1.8% during the first quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock worth $740,000 after acquiring an additional 11 shares during the period. Finally, Albion Financial Group UT increased its stake in shares of Mettler-Toledo International by 1.5% during the first quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock worth $890,000 after acquiring an additional 11 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insiders Place Their Bets

In other news, Director Thomas P. Salice sold 1,062 shares of the firm’s stock in a transaction on Wednesday, August 13th. The shares were sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the transaction, the director owned 283 shares of the company’s stock, valued at approximately $368,154.70. This trade represents a 78.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction on Friday, August 8th. The shares were sold at an average price of $1,254.09, for a total transaction of $376,227.00. Following the completion of the transaction, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,389,588.55. This represents a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,827 shares of company stock valued at $2,371,208 over the last quarter. Company insiders own 1.94% of the company’s stock.

Mettler-Toledo International Stock Up 4.2%

NYSE:MTD opened at $1,359.14 on Friday. The company has a market cap of $28.00 billion, a P/E ratio of 34.42, a P/E/G ratio of 3.91 and a beta of 1.37. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,438.46. The firm’s 50 day moving average is $1,285.43 and its two-hundred day moving average is $1,193.56.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. The company had revenue of $983.22 million for the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. Mettler-Toledo International’s revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the firm posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

MTD has been the topic of several recent analyst reports. Robert W. Baird upped their target price on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research report on Tuesday, October 7th. Bank of America upped their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Citigroup upped their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research note on Thursday, August 21st. Finally, JPMorgan Chase & Co. upped their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday, October 9th. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.